Celyad – Treating Acute Myeloid Leukemia and MM + 5 Solid Tumors With Stem Cells

Finding Genius Podcast

Richard Jacobs

Medicine, Health & Fitness

4.4 • 1K Ratings

🗓️ 6 March 2017

⏱️ 34 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Celyad is a biopharmaceutical company, specialized in cell therapy, developing landmark technologies aimed at treating severe diseases with poor prognoses. Their scientific approach is inspired by the natural mechanisms that are used by the body to fight diseases.
Georges Rawadi, VP business development talks to us about the latest in stem cell technology and how Celyad is revolutionizing the battle against cancer.
Georges shares how Celyad is working on battling cancer through stem cell technology. Specifically, AML (Acute Myeloid Leukemia) and MM + 5 solid tumors, the forms that are life threatening, with a handful of treatments.
With the current technology being limited and the government regulations being a barrier because of the years necessary for Stage 1 2 and 3 of clinical trials, commercializing these therapies takes years. So make sure you remain tuned to the podcast to be updated. Don't forget to listen, share and subscribe to the podcast.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Almost Here, Around the Corner of Future Technology Podcasts with Richard Jacobs.
0:07.9	Future Technologies are poised to transform our lives for better or worse for the focus of this podcast.
0:13.6	Almost here means these technologies are now here and starting to be used.
0:18.2	We're just around the corner.
0:19.7	From Bitcoin to artificial intelligence, 3D around the corner, from Bitcoin to artificial intelligence,
0:21.6	3D printing, blockchain, virtual reality, and more.
0:26.2	Hi, this is Richard Jacobs with Future Tech Podcast, almost here around the corner technologies.
0:32.8	Today I have an interesting guest, Georges Rwadi, VP of Business Development and Intellectual Property
0:38.7	at Seliad, C-E-L-Y-A-D.com.
0:43.4	Georges, how you doing?
0:45.1	Hi, how are you? I'm doing fine.
0:48.3	Thank you for coming, sir.
0:50.5	You're welcome. My pleasure.
0:53.1	Yeah, can you give listeners an overview of what Celiat does with stem cell technology?
1:00.0	Yes.
1:01.0	Well, I mean, Celad is a cell therapy company where, you know, our mission is to develop a
1:10.0	breakthrough technology for life-threatening disease.
1:15.0	And since our inception back in 2007, we have been developing cell therapy initially for cardiovascular diseases.
1:24.7	And since more than two years, we are also active in the cell-based
1:30.3	immunotherapy for cancer.
1:35.3	Definitely we are using different sources of cells, not only stem cell but also T-cell,
1:43.3	which are primary T-cell from patients.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.